Atrial fibrillation in end-stage renal disease

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 11, 2007, Pages 1391-1397

  Korantzopoulos, Panagiotis ^a   Kokkoris, Stelios ^b   Liu, Tong ^c   Protopsaltis, Ioannis ^b   Li, Guangping ^c   Goudevenos, John A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^c SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Arrhythmias; Atrial fibrillation; Cardiovascular complications; Chronic renal failure; End stage renal disease

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DILTIAZEM; IBUTILIDE; NADOLOL; PROPAFENONE; SOTALOL; VERAPAMIL;

CLINICAL FEATURE; END STAGE RENAL DISEASE; HEART ATRIUM FIBRILLATION; HUMAN; KIDNEY DISEASE; MORBIDITY; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; RISK FACTOR;

ATRIAL FIBRILLATION; COMORBIDITY; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 35948929144     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00877.x     Document Type: Review

References (57)

1. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 2006 27: 1979 2030.
2. Chen LY, Shen WK. Epidemiology of atrial fibrillation: A current perspective. Heart Rhythm 2007 4: S1 S6.
3. Thrall G, Lane D, Carroll D, Lip GY. Quality of life in patients with atrial fibrillation: A systematic review. Am J Med 2006 119: 448. e1-19.
4. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006 114: 119 125.
5. Korantzopoulos P, Kolettis TM, Goudevenos JA, Siogas K. Errors and pitfalls in the non-invasive management of atrial fibrillation. Int J Cardiol 2005 104: 125 130.
6. Dorian P. The future of atrial fibrillation therapy. J Cardiovasc Electrophysiol 2006 17 (Suppl 2 S11 S16.
7. Varma R, Garrick R, McClung J, Frishman WH. Chronic renal dysfunction as an independent risk factor fort he development of cardiovascular disease. Cardiol Rev 2005 13: 98 107.
8. Shik J, Parfrey PS. The clinical epidemiology of cardiovascular disease in chronic kidney disease. Curr Opin Nephrol Hypertens 2005 14: 550 557.
9. Hsu CY, Vittinghoff E, Lin F, Shlipak MG. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 2004 141: 95 101.
10. Kocheril AG. Arrhythmia issues in patients with renal disease. Semin Nephrol 2001 21: 57 65.
11. Abe S, Yoshizawa M, Nakanishi N, Yazawa T, Yokota K, Honda M, Sloman G. Electrocardiographic abnormalities in patients receiving hemodialysis. Am Heart J 1996 131: 1137 1144.
12. Vazquez E, Sanchez-Perales C, Borrego F, Garcia-Cortes MJ, Lozano C, Guzman M, Gil JM, et al. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J 2000 140: 886 890.
13. Fabbian F, Catalano C, Lambertini D, Tarroni G, Bordin V, Squerzanti R, Gilli P, et al. Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. Clin Nephrol 2000 54: 234 239.
14. Ansari N, Manis T, Feinfeld DA. Symptomatic atrial arrhythmias in hemodialysis patients. Ren Fail 2001 23: 71 76.
15. Abbott KC, Trespalacios FC, Taylor AJ, Agodoa LY. Atrial fibrillation in chronic dialysis patients in the United States: Risk factors for hospitalization and mortality. BMC Nephrol 2003 4: 1.
16. Genovesi S, Pogliani D, Faini A, Valsecchi MG, Riva A, Stefani F, Acquistapace I, et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 2005 46: 897 902.
17. Atar I, Konas D, Acikel S, Kulah E, Atar A, Bozbas H, Gulmez O, et al. Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol 2006 106: 47 51.
18. Vazquez-Ruiz de Castroviejo E, Sanchez-Perales C, Lozano-Cabezas C, Garcia-Cortes MJ, Guzman-Herrera M, Borrego-Utiel F, Lopez-Lopez J, et al. Incidence of atrial fibrillation in hemodialysis patients. A prospective long-term follow-up study. Rev Esp Cardiol 2006 59: 779 784.
19. Das M, Aronow WS, McClung JA, Belkin RN. Increased prevalence of coronary artery disease, silent myocardial ischemia, complex ventricular arrhythmias, atrial fibrillation, left ventricular hypertrophy, mitral annular calcium, and aortic valve calcium in patients with chronic renal insufficiency. Cardiol Rev 2006 14: 14 17.
20. Grande A. Atrial fibrillation and dialysis. A convergence of risk factors. Rev Esp Cardiol 2006 59: 766 769.
21. Vazquez E, Sanchez-Perales C, Lozano C, Garcia-Cortes MJ, Borrego F, Guzman M, Perez P, et al. Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am J Cardiol 2003 92: 868 871.
22. Podrid PJ. Etiology and pathogenesis of atrial fibrillation. In: Kowey PR, Naccarelli GV (eds.). Atrial Fibrillation. New York: Marcel Dekker 2005. Pages: 27 60.
23. Liu T, Li GP. Potential mechanisms between atrial dilatation and atrial fibrillation. Am Heart J 2006 151: e1.
24. Shiroshita-Takeshita A, Brundel BJJM, Nattel S. Atrial fibrillation: Basic mechanisms, remodeling and triggers. J Interv Card Electrophysiol 2005 13: 181 193.
25. Ravelli F. Mechano-electric feedback and atrial fibrillation. Prog Biophys Mol Biol 2003 82: 137 149.
26. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int 1998 54: 1720 1725.
27. Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C. Left atrial volume in end-stage renal disease: A prospective cohort study. J Hypertens 2006 24: 1173 1180.
28. Liu T, Li G. Pulmonary vein dilatation: Another possible crosslink between left atrial enlargement and atrial fibrillation? Int J Cardiol 2007 [Epub ahead of print].
29. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 1995 47: 884 890.
30. Korzets A, Ori Y, Herman M. Serum potassium levels and atrial fibrillation in hemodialysis patients. Nephrol Dial Transplant 2001 16: 1090.
31. Korantzopoulos P, Kolettis T, Siogas K, Goudevenos J. Atrial fibrillation and electrical remodeling: The potential role of inflammation and oxidative stress. Med Sci Monit 2003 9: RA225 RA229.
32. Boos CJ, Anderson RA, Lip GYH. Is atrial fibrillation an inflammatory disorder? Eur Heart J 2006 27: 136 149.
33. Liu T, Li G, Li L, Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: A meta-analysis. J Am Coll Cardiol 2007 In Press.
34. Iravanian S, Dudley SC. Oxidative stress in the pathogenesis of atrial fibrillation. Curr Cardiol Rev 2006 2: 247 254.
35. Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007 115: 135 143.
36. Stenvinkel P. Inflammation in end-stage renal disease: The hidden enemy. Nephrology 2006 11: 36 41.
37. Vidt DG. Inflammation in renal disease. Am J Cardiol 2006 97 (suppl 20A 27A.
38. Wratten ML, Galaris D, Tetta C, Sevanian A. Evolution of oxidative stress and inflammation during hemodialysis and their contribution to cardiovascular disease. Antioxid Redox Signal 2002 4: 935 944.
39. Himmelfarb J. Linking oxidative stress and inflammation in kidney disease: Which is the chicken and which is the egg? Semin Dial 2004 17: 449 454.
40. Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, Gialafos JE. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998 135: 733 738.
41. Dilaveris PE, Gialafos JE. P-wave dispersion: A novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol 2001 6: 159 165.
42. Szabo Z, Kakuk G, Fulop T, Matyus J, Balla J, Karpati I, Juhasz A, et al. Effects of haemodialysis on maximum P wave duration and P wave dispersion. Nephrol Dial Transplant 2002 17: 1634 1638.
43. Tezcan UK, Amasyali B, Can I, et al. Increased P wave dispersion and maximum P wave duration after hemodialysis. Ann Noninvasive Electrocardiol 2004 9: 34 38.
44. Madias JE. Increases in P-wave duration and dispersion after hemodialysis are totally (or partially) due to the procedure-induced alleviation of the body fluid overload: A hypothesis with strong experimental support. Ann Noninvasive Electrocardiol 2005 10: 129 133.
45. Jaroszynski AJ, Glowniak A, Sodolski T, et al. Effect of haemodialysis on signal-averaged electrocardiogram P-wave parameters. Nephrol Dial Transplant 2006 21: 425 430.
46. Koomans HA, Blankestijn PJ, Joles JA. Sympathetic hyperactivity in chronic renal failure: A wake-up call. J Am Soc Nephrol 2004 15: 524 537.
47. Chen J, Wasmund SL, Hamdan MH. Back to the future: The role of the autonomic nervous system in atrial fibrillation. Pacing Clin Electrophysiol 2006 29: 413 421.
48. Wiesholzer M, Harm F, Tomasec G, et al. Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation. Am J Nephrol 2001 21: 35 39.
49. Malyszko J, Malyszko JS, Pawlak D, Pawlak K, Buczko W, Mysliwiec M. Hemostasis, platelet function and serotonin in acute and chronic renal failure. Thromb Res 1996 83: 351 361.
50. Tveit DP, Hypolite IO, Hshieh P, Cruess D, Agodoa Ly, Welch PG, Abbott KC. Chronic dialysis patients have high risk for pulmonary embolism. Am J Kidney Dis 2002 39: 1011 1017.
51. Nishimura M, Hashimoto T, Kobayashi H, Fukuda T, Okino K, Yamamoto N, Iwamoto N, et al. The high incidence of left atrial appendage thrombosis in patients on maintenance haemodialysis. Nephrol Dial Transplant 2003 18: 2339 2347.
52. Zebe H. Atrial fibrillation in dialysis patients. Nephrol Dial Tranplant 2000 15: 765 768.
53. Drugs for the Heart. Opie LH, Gersh BJ (eds.). Sixth Edition. Elsevier Saunders, Philadelphia 2005.
54. Varriale P, Sedighi A. Acute management of atrial fibrillation and atrial flutter in the critical care unit: Should it be ibutilide? Clin Cardiol 2000 23: 265 268.
55. Lo DS, Rabbat CG, Clase CM. Thromboembolism and anticoagulant management in hemodialysis patients: A practical guide to clinical management. Thromb Res 2006 118: 385 395.
56. Vazquez E, Sanchez-Perales C, Garcia-Cortes MJ, Borrego F, Lozano C, Guzman M, Gil JM, et al. Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? Int J Cardiol 2003 87: 135 139.
57. Wright JR, Kalra PA. Ought dialysis patients with atrial fibrillation be treated with anticoagulants? Int J Cardiol 2003 87: 139 141.